Results 131 to 140 of about 364,574 (324)

A Case of Advanced Renal Cell Carcinoma With Concomitant Development of Multiple Endocrine Neoplasia Type 1 That Affected Treatment Progress With Immunotherapy

open access: yesIJU Case Reports, Volume 8, Issue 4, Page 338-342, July 2025.
ABSTRACT Introduction Hypercalcemia is a poor prognostic factor in advanced cancer. Case Presentation A patient with advanced clear cell renal carcinoma with hypercalcemia was treated with nivolumab+ipilimumab combination therapy. Treatment was discontinued after 4 months due to renal dysfunction.
Masataka Abe   +9 more
wiley   +1 more source

Ketotic Hypoglycaemia Following Sleeve Gastrectomy

open access: yesClinical Endocrinology, Volume 103, Issue 1, Page 45-49, July 2025.
ABSTRACT Post‐bariatric surgery hypoglycaemia is typically mediated by hyperinsulinaemia, although the exact mechanisms are incompletely understood. Two cases of non‐insulin mediated, ketotic hypoglycaemia following sleeve gastrectomy are presented. After fasting for 40 and 65 h, respectively, both patients developed symptomatic hypoglycaemia, with ...
Jinwen He   +3 more
wiley   +1 more source

Pituitary Apoplexy in a Woman with Chromophobe Adenoma [PDF]

open access: bronze, 1969
G Tevaarwerk   +2 more
openalex   +1 more source

Anacardic acid induces caspase-independent apoptosis and radiosensitizes pituitary adenoma cells.

open access: yesJournal of Neurosurgery, 2011
OBJECT Pituitary adenomas, which are common intracranial tumors, are associated with significant patient morbidity due to hormone secretion or mass effect or as a complication of therapy.
Sangeetha Sukumari-Ramesh   +4 more
semanticscholar   +1 more source

Morning Salivary Cortisone Versus Serum Cortisol in the Overnight Dexamethasone Suppression Test (ODNST): Evaluation in a Clinical Setting

open access: yesClinical Endocrinology, Volume 103, Issue 1, Page 13-20, July 2025.
ABSTRACT Introduction Saliva hormone measurement is increasingly being applied in everyday clinical practice. In relation to salivary cortisone measurement, there is a particular advantage, with minimal chance of cross‐reaction with prescribed glucocorticoids and greater convenience.
Mathilde Mordaunt   +10 more
wiley   +1 more source

Pediatric Pituitary Adenomas

open access: yesArchives of Pathology & Laboratory Medicine, 2008
Abstract Context.—Pituitary adenomas are relatively rare occurrences in the pediatric population, and there are few studies documenting the profile of these tumors in this age group. Objective.—To study the clinical and pathologic features of pediatric pituitary adenomas in conjunction with a review of the available ...
Christopher Webb, Richard A. Prayson
openaire   +3 more sources

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

open access: yesClinical Endocrinology, Volume 103, Issue 1, Page 50-56, July 2025.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source

Roles and Impacts of Integrative Medical Interventions in Central Nervous System Tumor Treatment: Multi‐Technology Convergence and the Paradigm Shift Toward Functional Reconstruction

open access: yesCNS Neuroscience &Therapeutics, Volume 31, Issue 7, July 2025.
Multi‐technology interventions (non‐invasive neuromodulation, AI, 3D organoids) for CNS tumor treatment shift from monotherapy to functional reconstruction. They address BBB restriction, tumor heterogeneity, and immune suppression via biological–psychological–technological convergence, enabling precision oncology through dynamic monitoring and ...
Junda Lai   +5 more
wiley   +1 more source

Case Series Study of Visual Field Defects in Pituitary Gland Tumors [PDF]

open access: yesAl Ameen Journal of Medical Sciences, 2017
Background: The pituitary gland is a small endocrine gland, weighing about 500 mg. Pituitary adenomas account for 12-15 % of all intracranial tumors. Pituitary gland is in the sella turcica, 8-13 mm lower than the optic chiasm.
Vallabha K, Vijayamahantesh M. Bijapur
doaj  

Home - About - Disclaimer - Privacy